Effect of modifications of the Alkylpiperazine moiety of trazodone on 5HT2A and α1 receptor binding affinity

被引:30
作者
Giannangeli, M
Cazzolla, N
Luparini, MR
Magnani, M
Mabilia, M
Picconi, G
Tomaselli, M
Baiocchi, L
机构
[1] Angelini Ric SpA, Dept Med Chem, I-00040 S Palomba Pomezia, Rm, Italy
[2] Angelini Ric SpA, Dept Neuropharmacol, I-00040 S Palomba Pomezia, Rm, Italy
[3] Soluz Informat SAS, I-36100 Vicenza, Italy
关键词
D O I
10.1021/jm970700n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of triazolopyridine derivatives (compounds 2a-I) were synthesized in order to-explore the effect of modifications of the alkylpiperazine moiety of trazodone (fragment A) on binding affinity for 5HT(2A) and alpha(1) receptors. All of the synthesized compounds show a decrease of affinity for both 5HT(2A) and alpha(1) receptors, as compared to trazodone, with the exception of compounds 2b,c which bear a methyl group in an alpha position to the aliphatic nitrogen atom N-1. These compounds showed a decrease of affinity only for the alpha(1) receptor. The stereochemical influence of the piperazine moiety of compound 2c was also evaluated. Enantiomer (S)-2c showed the most significant differences between 5HT(2A) and alpha(1) receptor affinity (IC50 values) and among the corresponding functional properties (pA(2) values). Since (S)-2c cannot generate the metabolite 4-(3-chlorophenyl)piperazine this product was selected for further pharmacological studies.
引用
收藏
页码:336 / 345
页数:10
相关论文
共 30 条
[1]   PRE-SYNAPTIC AND POSTSYNAPTIC EFFECTS OF SULPIRIDE IN THE RAT ISOLATED VAS-DEFERENS [J].
BADIA, A ;
BERMEJO, P ;
JANE, F .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (04) :266-268
[2]  
Baiocchi L, 1974, Boll Chim Farm, V113, P152
[3]  
BAIOCCHI L, 1994, Patent No. 02061
[4]  
BAIOCCHI L, 1996, Patent No. 623131
[5]  
BONACCORSI A, 1972, SPERIMENTAZIONE FARM
[6]   PROSPECTS FOR IMPROVED ANTIDEPRESSANTS [J].
BROEKKAMP, CLE ;
LEYSEN, D ;
PEETERS, BWMM ;
PINDER, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (23) :4615-4633
[7]   (-)-M-CHLOROPHENYL-PIPERAZINE, A CENTRAL 5-HYDROXYTRYPTAMINE AGONIST, IS A METABOLITE OF TRAZODONE [J].
CACCIA, S ;
BALLABIO, M ;
SAMANIN, R ;
ZANINI, MG ;
GARATTINI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (07) :477-478
[8]   SYNTHESIS AND TRAZODONE-LIKE PHARMACOLOGICAL PROFILE OF 1- AND 2-[3-[4-(X)-1-PIPERAZINYL]-PROPYL]BENZOTRIAZOLES [J].
CALIENDO, G ;
DICARLO, R ;
MELI, R ;
PERISSUTTI, E ;
SANTAGADA, V ;
SILIPO, C ;
VITTORIA, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1993, 28 (12) :969-974
[9]  
COHEN ML, 1981, J PHARMACOL EXP THER, V218, P421
[10]   The replacement of the hydroxyl group of ethyl (+)Lactate by halogens, and the molecular dissymmetry of derivatives of ethyl lactate which contain the sulphin group. [J].
Gerrard, W ;
Kenyon, J ;
Phillips, H .
JOURNAL OF THE CHEMICAL SOCIETY, 1937, :153-158